Skip to content

Effect of Early Low Resisted Exercise With Blood Flow Restriction on Pulmonary Function in Post Cardiac Surgery Patient

Effect of Early Low Resisted Exercise With Blood Flow Restriction on Pulmonary Function in Post Cardiac Surgery Patient

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06956911
Enrollment
50
Registered
2025-05-04
Start date
2024-11-07
Completion date
2025-06-15
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting, Post Coronary Artery Bypass Grafting

Keywords

Post Coronary Artery Bypass Grafting

Brief summary

After cardiac surgery Patients present a loss of exercise capacity, muscle mass, and quality of life Cardiopulmonary rehabilitation aims to reduce the loss of muscle strength, size and increase cardiopulmonary function so that quality of life is maintained as much as possible after open-heart surgeries. Traditionally, cardiac rehabilitation consist of low-intensity aerobic exercise. Therefore, cardiac rehabilitation should include not only aerobic but also resistance training (RT),. A safe and effective version of RT is needed that can still improve muscle strength and size in patients early after cardiac surgery,It is found that BFR can achieve the same result with low intensity which is suitable for patient post cardiac surgery,so the result of this study will provide a safe resisted exercise useful for post cardiac surgery patient

Interventions

DEVICEtraditional cardiac rehabilitation with early low resisted exercise with blood flow restriction

Traditional cardiac rehabilitation and early low resisted exercise with 0.5 kilogram in form of bilateral upper limb exercise (elbow flexion and extension,wrist flexion and extension ) with external pressure applied with pressure cuff which determined by 40% of systolic blood pressure which applied on the proximal part of the arm,the frequency of exercise is once per day for 14 consecutive day and intensity determined by rate of perceived exertion scale

Diaphragmatic and costal breathing exercise, active assisted to active range of motion,percussion,splinted cough,early mobility, upper limb exercise with breathing and incentive spirometer

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male patient aged from 45-60 * Elective open heart surgery via median sternotomy * Post operative, extubated post open heart surgery, who can follow the instructions and sign the consent form * Hemodynamic stability * Neurological stability

Exclusion criteria

* Still on mechanical ventilation more than 48 hours * Neuromuscular diseases * Rheumatoid arthritis * Coagulopathy * Chronic Obstructive Pulmonary Disease (COPD) * Cardiac arrhythmias

Design outcomes

Primary

MeasureTime frameDescription
pulmonary function test, parameters that be measured is FVC and will be expressed as % of the predicted value for age,height,weight and sex and FEV1 and will be expressed as % of the predicted value of age ,sex,weight and heightfourteen daysparameters that be measured is FVC and will be expressed as % of the predicted value for age, height ,weight and sex and FEV1 and will be expressed as % of the predicted value of age ,sex, weight and height
Hand grip strengthfourteen daysmeasure hand grip strength by hand held dynamometer (digital apperatus) expressed by kilogram
c-reactive protein labfourteen days
Functional capacityfourteen days ,first measure will be at the session of assessment and last measure will be at the end of treatment program after fourteen daysmeasure functional capacity by six minute walk test by calculate the total distance covered by the patient expressed by meters

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026